Vimarsana.com

generic drug: Live & Latest News Updates : Vimarsana.com

Will The White House's Plan To Curb Drug Shortages Work?

The plan proposes incentives and penalties to induce more resilient sourcing, but does not promote testing to help purchasers identify high-quality manufacturers.

United-states
China
White-house
District-of-columbia
The-white-house
India
America
American
Lael-brainard
Ricardo-martinez
Neera-tanden
Hospital-resilient-supply-program

GCC Generic Drugs Market Report 2024-2032: Trends, Shares, and Growth Opportunities Across Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, and Oman

GCC Generic Drug Market GCC Generic Drug Market Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The GCC generic drug market reached US$ 5.8 Billion in 2023. Looking forward, the market is projected to reach US$ 14.7 Billion by 2032, exhibiting a growth rate (CAGR) of 10.9% during 2023-2032. At present, there is a rise in the demand for gene

Saudi-arabia
Kuwait
Oman
Dublin
Ireland
Qatar
Bahrain
United-arab-emirates
Health-insurance-policy
Drug-market
Industry-trends

McDermottPlus Check-Up: February 16, 2024 | McDermott+Consulting

House Energy and Commerce Health Subcommittee Holds Legislative Hearing on 19 Bills. Lawmakers discussed 19 pieces of legislation designed to support patients and caregivers in the key...

United-states
New-mexico
Massachusetts
Maryland
Michigan
Iowa
Minnesota
American
America
Medicare-prescription-payment-program
Us-department-of-health

Zydus Lifesciences gets USFDA nod for generic drug to prevent chest pain in heart patients

Zydus Lifesciences Ltd announced on Friday that it has attained final approval from the US health regulatory authority to produce and distribute its generic Isosorbide Mononitrate extended-release tablets. These tablets are utilized for preventing chest pain in patients with specific heart conditions.

New-delhi
Delhi
India
Ahmedabad
Gujarat
Isosorbide-mononitrate
Zydus-lifesciences
Drug-administration
Zydus-lifesciences-ltd-on
Zydus-lifesciences-ltd
Isosorbide-mononitrate-extended-release
Generic-drug

Healthcare Administration and Regulation Update for February 16,

Healthcare Administration and Regulation Update for February 16,
natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.

Michigan
United-states
Maryland
New-mexico
Minnesota
Iowa
Massachusetts
American
America
Human-service
Payer-health-equity

Malaria Treatment Market Size to Hit 28.5% CAGR, Globally, by 2030 - Exclusive Report by The Insight Partners

The global malaria treatment market revenue to reach $24.48 Billion by 2030.Pune, India, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Malaria is a serious infection spread by an infected mosquito. The infection is very common in certain parts of the world, such as large areas of Africa and Asia, Central and South America, and the Dominican Republic and Haiti. However, malaria is an entirely preventable and treatable disease if tackled at an early stage. For example, malaria is treated with a prescription d

Italy
France
Kenya
Uganda
Germany
Dominican-republic
Angola
Malawi
India
Spain
United-kingdom
Pune

Generic PrEP use could reduce new HIV acquisitions, save lives among young men who have sex with men

Anne Neilan, MD, a physician-scientist in the division of Infectious Diseases at Massachusetts General Hospital is the senior author of a recently published paper in Clinical Infectious Diseases, Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-Saving at Generic Drug Price.

United-states
Massachusetts
Anne-neilan
Danielle-ellis
Young
Medicine-trials-network
Infectious-diseases
Massachusetts-general-hospital
Clinical-infectious-diseases
Daily-oral
Generic-drug
Braidwood-management

vimarsana © 2020. All Rights Reserved.